Ironwood Pharmaceuticals | IRWD - Passività Correnti





Passività Correnti Cambiamento Data
Acadia Pharmaceuticals USD 332.22M 29.22M 2026-09
Agios Pharmaceuticals USD 77.59M 7.37M 2026-09
Akebia Therapeutics USD 162.35M 1.48M 2026-09
Almirall EUR 323.65M 26.99M 2026-06
Alnylam Pharmaceuticals USD 2.06B 550.49M 2026-09
Amarin USD 175.14M 10.94M 2026-09
Ardelyx USD 127.8M 4.42M 2026-09
Astellas Pharma JPY 1.1T 134.96B 2026-09
AstraZeneca USD 31.27B 286M 2026-09
Charles River Laboratories USD 1.09B 45.49M 2026-09
Coherus Biosciences USD 75.51M 56.82M 2026-06
Emergent BioSolutions USD 651.3M 12.7M 2023-12
Halozyme Therapeutics USD 476.09M 131.65M 2026-09
Incyte USD 1.44B 125.72M 2026-09
Ironwood Pharmaceuticals USD 34.73M 1.88M 2026-09
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
Lexicon Pharmaceuticals USD 9.9M 10.97M 2026-03
MacroGenics USD 107.23M 1.58M 2026-09
Moderna USD 2.03B 506M 2026-09
Myriad Genetics USD 130.7M 500K 2026-06
Pacira USD 126.1M 4.08M 2026-09
PTC Therapeutics USD 776.08M 5.01M 2026-09
Puma Biotechnology USD 82.73M 3.63M 2025-09
Sarepta Therapeutics USD 656.35M 153.44M 2026-09
Takeda JPY 2.6T 161B 2026-09
Ultragenyx Pharmaceutical USD 389M 38M 2026-09
Vanda Pharmaceuticals USD 145.16M 27.29M 2025-12